CD8A and neoplasm: Cox regression analysis found that RADIL still affected kidney cancer development along with age (P < 0.001), stage III (P = 0.001), stage IV (P < 0.001), and tumor-infiltrating CD8+ T cells (P < 0.001) which were completely negative in the kidney cancer development (Figure 7A).